谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Brigatinib Restores Disease Control at Second Progression on Osimertinib in Metastatic EGFR Ex19del Mutated NSCLC with Acquired EML4-ALK Fusion

E. M. Urbanska,J. B. Sorensen,M. Grauslund,J. O. Lofgren,E. Santoni-Rugiu

JOURNAL OF THORACIC ONCOLOGY（2023）

引用 0|浏览6
关键词
acquired,EML4-ALK fusion,Brigatinib and Osimertinib,second re-biopsy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要